Gadolinium deposition in nephrogenic fibrosing dermopathy

被引：314

作者：

Boyd, Alan S.

Zic, John A.

Abraham, Jerrold L.

机构：

[1] Vanderbilt Univ, Dept Med Dermatol, Nashville, TN USA

[2] Vanderbilt Univ, Dept Pathol, Nashville, TN USA

[3] SUNy Upstate Med Univ, Dept Pathol, Syracuse, NY USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2007年 / 56卷 / 01期

关键词：

D O I：

10.1016/j.jaad.2006.10.048

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

There is growing recognition of the association between the use of gadolinium-containing radiocontrast agents for magnetic resonance imaging and the serious dermal and systemic disease nephrogenic fibrosing dermopathy/nephrogenic Systemic fibrosis (NFD/NSF), The pathogenesis of this entity remains unclear, however, our recent observations Suggest a likely mechanism for the initial dermal manifestations of this gadolinium toxicity.

引用

收藏

页码：27 / 30

页数：4

相关论文

共 10 条

[1] Editorial: Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis - Setting the record straight [J].

Cowper, SE ;

Bucala, R ;

Leboit, PE .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2006, 35 (04) :208-210

[2] Nephrogenic fibrosing dermopathy [J].

Cowper, SE ;

Su, LD ;

Bhawan, J ;

Robin, HS ;

LeBoit, PE .

AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2001, 23 (05) :383-393

[3] Scleromyxoedema-like cutaneous diseases in renal-dialysis patients [J].

Cowper, SE ;

Robin, HS ;

Steinberg, SM ;

Su, LD ;

Gupta, S ;

LeBoit, PE .

LANCET, 2000, 356 (9234) :1000-1001

[4]

*CTR DRUG EV RES, 2006, US FDA WEB SIT PUBL

[5] Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? [J].

Grobner, T .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (04) :1104-1108

[6] Nephrogenic systemic fibrosis: Suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging [J].

Marckmann, Peter ;

Skov, Lone ;

Rossen, Kristian ;

Dupont, Anders ;

Damholt, Mette Brimnes ;

Heaf, James Goya ;

Thomsen, Henrik S. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (09) :2359-2362

[7] Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature [J].

Mendoza, FA ;

Artlett, CM ;

Sandorfi, N ;

Latinis, K ;

Piera-Velazquez, S ;

Jimenez, SA .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2006, 35 (04) :238-249

[8] Presence of CD45RO+ CD34+ cells with collagen synthesis activity in nephrogenic fibrosing dermopathy: a new pathogenic hypothesis [J].

Ortonne, N ;

Lipsker, D ;

Chantrel, F ;

Boehm, N ;

Grosshans, E ;

Cribier, B .

BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (05) :1050-1052

[9] Gadolinium chloride toxicity in the rat [J].

Spencer, AJ ;

Wilson, SA ;

Batchelor, J ;

Reid, A ;

Rees, J ;

Harpur, E .

TOXICOLOGIC PATHOLOGY, 1997, 25 (03) :245-255

[10] Nephrogenic fibrosing dermopathy with systemic involvement [J].

Ting, WW ;

Stone, MS ;

Madison, KC ;

Kurtz, K .

ARCHIVES OF DERMATOLOGY, 2003, 139 (07) :903-906